AmerisourceBergen Selected Exclusive Physician Distributor and Reimbursement Support for New Biotech Drug Launch.Business Editors/Health & Medical Writers VALLEY FORGE Valley Forge, on the Schuylkill River, SE Pa., NW of Philadelphia. There, during the American Revolution, the main camp of the Continental Army was established (Dec., 1777–June, 1778) under the command of Gen. George Washington. , Pa.--(BUSINESS WIRE)--Jan. 31, 2003 Specialty Group Crafts Support Program For Biogen's Launch of AMEVIVE(R)(alefacept) AmerisourceBergen Corporation (NYSE NYSE See: New York Stock Exchange :ABC ABC in full American Broadcasting Co. Major U.S. television network. It began when the expanding national radio network NBC split into the separate Red and Blue networks in 1928. ), the largest pharmaceutical services company focused solely on the pharmaceutical supply channel, today announced that its Specialty Group has been selected as the physician distributor and reimbursement support provider for the launch of AMEVIVE(R) (alefacept), a recently approved drug In the United States, the FDA approves drugs. Before a drug can be prescribed, it must undergo an extensive FDA approval process. This process involves first testing the drug on animals or in medical labs. from Biogen, Inc. for the treatment of moderate-to-severe chronic plaque psoriasis. AMEVIVE will be provided to patients primarily through dermatologists that specialize in psoriasis and other skin diseases. The new treatment is administered in the physician's office by injection and requires weekly blood monitoring. To ensure patient safety and appropriate administration of AMEVIVE, Biogen built an integrated service model to help facilitate reimbursement, provide patient support, and manage product distribution. In winning the business, AmerisourceBergen Specialty Group  This article or section is written like an .Please help [ rewrite this article] from a neutral point of view. Mark blatant advertising for , using . created a streamlined, physician-oriented solution for Biogen. The Group will provide patient reimbursement support by coordinating patient insurance benefits; manage just-in-time delivery of AMEVIVE to physicians for treatment; and provide information technology resources to support sales activities with a dedicated ordering and reporting portal. "We are very pleased that Biogen is using our physician distribution and reimbursement expertise to help launch this exciting new drug," said Steven Collis, Senior Vice President and President AmerisourceBergen Specialty Group. "By leveraging across our portfolio of specialty services, we can deliver customized, integrated solutions that assist manufacturers in efficiently bringing new pharmaceuticals to market." "We have worked together with AmerisourceBergen's specialty team to develop a responsive and customized supply model to support the launch of AMEVIVE," said Chris Dillon, Biogen's Director of Strategic Product Support. "This unique approach allows us to establish and strengthen our relationship with this physician community, while at the same time supporting our needs for management and distribution of AMEVIVE in the channel." Psoriasis is a T-cell mediated inflammatory skin disease that can cause considerable discomfort. It is a disease for which there is no cure, affecting people of all ages. According to according to prep. 1. As stated or indicated by; on the authority of: according to historians. 2. In keeping with: according to instructions. 3. the American Academy of Dermatology The American Academy of Dermatology (AAD) is the largest organization of dermatologists in the world. The Academy grants Fellowships and Associate Memberships, as well as Fellowships for Nonresidents (of the United States of America or Canada). , psoriasis affects three to five million people in the United States. Although individuals with mild psoriasis can often control their disease with topical agents, more than one million patients worldwide require ultraviolet or systemic immunosuppressive therapy Immunosuppressive therapy Medical treatment in which the immune system is purposefully thwarted. Such treatment is necessary, for example, to prevent organ rejection in transplant cases. . According to the National Psoriasis Foundation The National Psoriasis Foundation is a patient-driven, non-profit US-based psoriasis education and advocacy group. The National Psoriasis Foundation's mission is to improve the quality of life of the millions of Americans with psoriasis and/or psoriatic arthritis by promoting , the disease impacts a person's psychological well-being psychological well-being Research A nebulous legislative term intended to ensure that certain categories of lab animals, especially primates, don't 'go nuts' as a result of experimental design or conditions and social functioning social functioning, n the ability of the individual to interact in the normal or usual way in society; can be used as a measure of quality of care. , as well as their physical functioning. About AmerisourceBergen AmerisourceBergen (NYSE:ABC) is the largest pharmaceutical services company in the United States dedicated solely to the pharmaceutical supply chain. It is a leading distributor of pharmaceutical products and services to the hospital systems/acute care market, physicians, alternate care and mail order facilities, independent community pharmacies, and regional chain pharmacies. The Company is also a leader in the institutional pharmacy marketplace. With more than $40 billion in annualized annualized Of or relating to a variable that has been mathematically converted to a yearly rate. Inflation and interest rates are generally annualized since it is on this basis that these two variables are ordinarily stated and compared. operating revenue operating revenue Revenue from any regular source. Revenue from sales is adjusted for discounts and returns when calculating operating revenue. Compare other revenue. , AmerisourceBergen is headquartered in Valley Forge, PA, and employs more than 13,000 people serving over 25,000 customers. For more information go to www.amerisourcebergen.com. Forward-Looking Statements This news release may contain certain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances. Actual results may vary materially from the expectations contained in the forward-looking statements. Forward-looking statements may include statements addressing future financial and operating results of AmerisourceBergen and the benefits and other aspects of the 2001 merger between AmeriSource Health Corporation and Bergen Brunswig Corporation. The following factors, among others, could cause actual results to differ materially from those described in any forward-looking statements: the risk that the businesses of AmeriSource and Bergen Brunswig will not be integrated successfully; failure to obtain and retain expected synergies; and other economic, business, competitive and/or regulatory factors affecting the business of AmerisourceBergen generally. More detailed information about these factors is set forth in AmerisourceBergen's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. for fiscal 2002. AmerisourceBergen is under no obligation to (and expressly disclaims any such obligation to) update or alter any forward-looking statements whether as a result of new information, future events or otherwise. (C) Copyright 2003 AmerisourceBergen Corporation. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion